Omega-3 fatty acids are the most studied supplement in the history of nutritional medicine. There are over 30,000 peer-reviewed studies on EPA and DHA in the scientific literature. The benefits documented across that body of research — cardiovascular protection, anti-inflammatory activity, brain function, metabolic health, joint integrity — are not fringe claims. They are among the most replicated findings in nutritional science. And yet, the average American adult consumes approximately 100 mg of EPA+DHA per day. The therapeutic range that produces clinical benefit in studies starts at 1,000–2,000 mg. There’s a 10-to-20x gap between what most people get and what the evidence supports.
The anti-inflammatory effects of omega-3 are also directly relevant to sleep quality. Elevated inflammatory cytokines (IL-6, TNF-alpha) are primary upstream drivers of HPA axis hyperactivation — keeping cortisol elevated at night and suppressing deep slow-wave sleep. Reducing inflammatory burden through adequate EPA+DHA is part of a complete protocol for anyone dealing with sleep disruption. Read my post on cortisol, HPA dysfunction, and sleep to understand the full mechanism.
Quick answer: The minimum effective dose of combined EPA+DHA for cardiovascular and anti-inflammatory benefit is 1,000–2,000 mg daily from fish oil or algae oil — not from flaxseed. The omega-3 index (the percentage of EPA+DHA in red blood cell membranes) is the only meaningful way to assess your status; values below 4% carry significantly elevated cardiovascular risk. Most Americans fall in the 4–6% range; the target for long-term health optimization is 8–12%. High-quality fish oil is the most cost-effective way to reach this, but the triglyceride form is substantially more bioavailable than ethyl ester form found in most cheap supplements.
I’m a surgeon. I see the downstream consequences of chronic inflammation — in tendons, joints, cardiovascular tissue, and the healing capacity of surgical wounds. What the research has taught me over the past decade is that omega-3 status is a meaningful modifier of every single one of those outcomes. A patient with an omega-3 index of 8% heals faster, has less peri-operative inflammation, and has better long-term outcomes than a patient at 4%. This is not speculative — it’s documented in orthopedic, cardiovascular, and wound healing literature.
But the gap between what most people take (either nothing or a cheap, poorly absorbed supplement at a subtherapeutic dose) and what actually produces clinical benefit is enormous. This post closes that gap — completely.
What Omega-3 Actually Does in Your Body
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the two biologically active omega-3 fatty acids. They are incorporated into every cell membrane in the human body — literally part of the physical structure of your cells. Their concentration in cell membranes determines membrane fluidity, receptor sensitivity, inflammatory signaling, and the production of specialized pro-resolving mediators (SPMs) — the molecules responsible for actively resolving inflammation rather than just suppressing it.
Cardiovascular Protection
The cardiovascular evidence for omega-3 is extensive. EPA and DHA reduce triglycerides by 15–30% at doses of 2,000–4,000 mg daily — a magnitude that equals many prescription drugs. They reduce platelet aggregation, improve endothelial function, lower resting heart rate, and have anti-arrhythmic properties. The REDUCE-IT trial (2018, published in the New England Journal of Medicine) found that high-dose EPA supplementation (4,000 mg icosapentaenoic acid daily) reduced major cardiovascular events by 25% and cardiovascular death by 20% in patients with elevated triglycerides. This is a pharmaceutical-grade intervention using a concentrated omega-3 form — but it tells you something important about the dose-response relationship.
Inflammation Resolution (Not Just Suppression)
Here’s the piece most omega-3 discussion misses: omega-3s don’t just reduce inflammation — they actively resolve it. EPA and DHA are precursors to resolvins, protectins, and maresins — the body’s endogenous anti-inflammatory and pro-resolution molecules. This distinction matters clinically. Chronic inflammation in joints, tendons, arteries, and metabolic tissue isn’t just about too much inflammation being produced; it’s about inadequate resolution. Omega-3s address both sides of that equation. This is directly relevant to everything from chronic plantar fasciitis to atherosclerosis to metabolic syndrome.
Brain and Cognitive Function
DHA comprises approximately 30–40% of the fatty acids in the brain. It’s a structural component of neuronal membranes and synaptic terminals — not an optional additive. Adequate DHA supports neuroplasticity, synaptic function, and the production of neuroprotectin D1, a potent anti-neuroinflammatory molecule. Epidemiological studies consistently link higher omega-3 intake and higher omega-3 index values with lower rates of cognitive decline, Alzheimer’s disease, and depression. A 2022 meta-analysis in Translational Psychiatry found that EPA supplementation significantly reduced depressive symptoms in patients with clinical depression.
Metabolic Health
Omega-3s improve insulin receptor sensitivity, reduce liver fat accumulation (non-alcoholic fatty liver disease), and lower the chronic low-grade inflammation that drives insulin resistance. If you’re tracking your HbA1c and metabolic markers, optimizing omega-3 status is one of the highest-leverage non-pharmacological interventions for improving those numbers over 3–6 months.
EPA vs DHA: Why Both Forms Matter
EPA and DHA have overlapping but distinct biological roles:
EPA (Eicosapentaenoic Acid)
EPA is the primary anti-inflammatory omega-3. It competes with arachidonic acid (the pro-inflammatory omega-6) for the same enzymes, reducing production of inflammatory eicosanoids. EPA is the dominant component for cardiovascular benefit, triglyceride reduction, and depression management. The REDUCE-IT trial used EPA-only (as Vascepa/icosapentaenoic acid) at high doses — the most impressive cardiovascular omega-3 data to date.
DHA (Docosahexaenoic Acid)
DHA is the primary structural omega-3 — the one physically incorporated into brain, retinal, and neuronal tissue. It’s more important for cognitive function, eye health, fetal brain development, and neurological integrity. DHA can be partially converted to EPA in the body (at low efficiency), but EPA cannot be efficiently converted to DHA. This asymmetry is why you need both — DHA-only supplements don’t cover EPA’s anti-inflammatory function.
For most adults, a balanced EPA:DHA ratio of 3:2 or 2:1 (more EPA than DHA) is the standard recommendation in most clinical research. If you have specific depression, cardiovascular, or joint concerns, leaning toward higher EPA is evidence-supported. For neurological protection and cognitive optimization, higher DHA content is preferable.
Fish Oil Forms: Why Your Supplement Choice Matters More Than You Think
This is where most omega-3 guidance fails the consumer. Not all fish oil is equivalent — and the difference in bioavailability between forms is clinically significant.
Ethyl Ester (EE) — The Most Common, Worst Form
Most fish oil supplements on the market are in the ethyl ester form — including many expensive brands. Ethyl ester is produced by reacting fish oil with ethanol to concentrate the EPA and DHA. The resulting product has significantly lower bioavailability: approximately 73% compared to the natural triglyceride form in the same study conditions. Ethyl ester also requires pancreatic enzymes and bile for absorption, making it highly meal-dependent. Taking EE fish oil without a fat-containing meal can reduce absorption by 50%+. The label usually doesn’t say “ethyl ester” — it’s identified by the total EPA+DHA on the label being much higher than the “from fish oil” amount.
Triglyceride (TG) Form — The Gold Standard
Natural fish oil exists as triglycerides — glycerol backbone with fatty acids attached. This is the form your digestive system recognizes and absorbs most efficiently. Studies consistently show 70–90% better absorption of EPA+DHA from triglyceride form compared to ethyl ester. Re-esterified triglyceride (rTG) fish oil goes one step further — concentrating EPA+DHA to 60–90% of total fatty acids while restoring the triglyceride structure. rTG fish oil is the most bioavailable and most potent form available without a prescription.
Phospholipid Form (Krill Oil)
Krill oil delivers omega-3s in phospholipid form, which is water-miscible and doesn’t require bile for absorption. Some studies show superior absorption and better brain uptake compared to fish oil. However, krill oil contains substantially lower concentrations of EPA+DHA per gram — making it far more expensive to reach therapeutic doses. For someone targeting 2,000+ mg EPA+DHA daily, krill oil is impractical. Krill’s main advantage is for people who want a smaller daily dose for general health maintenance or who can’t tolerate standard fish oil.
Algae Oil — For Vegetarians and Vegans
Fish don’t make omega-3 — they accumulate it from the algae and microorganisms they eat. Algae oil goes directly to the source, providing DHA and increasingly EPA in phospholipid form. Bioavailability is good and it’s free from ocean contaminant concerns (heavy metals, PCBs). The downside: DHA-dominant profile (many algae oils have little EPA) and higher cost per gram of EPA+DHA. For vegans, algae-based rTG EPA+DHA products are now available and represent the most clinically practical option.
What About Flaxseed and Plant Omega-3s?
Flaxseed, chia, and walnuts contain ALA (alpha-linolenic acid) — a plant omega-3. ALA must be converted by the body to EPA and DHA to be biologically useful. The conversion efficiency is poor: only 5–10% of ALA converts to EPA, and less than 1% converts to DHA. You cannot meaningfully raise your EPA and DHA status through plant omega-3s alone. Plant sources of ALA are not a substitute for EPA+DHA supplementation. Period.
How to Dose Omega-3 for Real Clinical Benefit
The most important number on a fish oil label is not the total fish oil per capsule — it’s the EPA+DHA content. A “1,000 mg fish oil” capsule typically contains only 300 mg EPA+DHA (30% concentration, standard cheap fish oil). A high-quality rTG concentrate provides 800–900 mg EPA+DHA per capsule (80–90% concentration).
Dosing by Goal
- General health maintenance: 1,000–2,000 mg EPA+DHA daily. Raises omega-3 index by approximately 1–2% over 3–4 months in most adults.
- Cardiovascular risk reduction: 2,000–4,000 mg EPA+DHA daily. This is the range used in most positive cardiovascular trials.
- Triglyceride reduction: 3,000–4,000 mg EPA+DHA daily. Clinically meaningful TG reduction requires consistent dosing at this level for 8–12 weeks.
- Joint and tendon recovery: 2,000–3,000 mg EPA+DHA daily. This is the range that consistently reduces inflammatory markers (CRP, IL-6) in musculoskeletal studies.
- Depression (adjunct): 1,000–2,000 mg EPA-dominant daily, with a minimum EPA:DHA ratio of 3:2.
Always take fish oil with a meal containing fat. This dramatically improves absorption — particularly for ethyl ester forms — and eliminates the “fish burp” that most people find objectionable. Evening with dinner is the most practical timing for most people.
Omega-3 and vitamin D synergy: Omega-3s and vitamin D3 have complementary and partially additive anti-inflammatory effects. Both reduce NF-κB signaling, both improve insulin sensitivity, and both support cardiovascular and neurological function through different mechanisms. Taking them together is more effective than either alone for the full spectrum of metabolic optimization.
The Omega-3 Index: The Test Your Doctor Never Orders
The omega-3 index measures the percentage of EPA+DHA in red blood cell membranes — a 3-month reflection of your average omega-3 status. It’s the most clinically validated biomarker for omega-3 status and is strongly predictive of cardiovascular outcomes, independent of LDL cholesterol.
- Under 4%: High-risk zone. Associated with 90% increased risk of sudden cardiac death compared to 8%+ in major studies. Most Americans eating the standard Western diet fall here.
- 4–8%: Average range. Still associated with elevated cardiovascular and inflammatory risk. Most people who take standard fish oil supplements land in this range.
- 8–12%: Optimal range. Associated with lowest cardiovascular risk, best cognitive outcomes, and optimal anti-inflammatory status. Requires consistent supplementation at therapeutic doses — typically 2,000+ mg EPA+DHA daily.
The omega-3 index is not routinely ordered by most physicians because it’s not standard of care — the same reason most doctors don’t order the complete metabolic lab tests most adults need. You can order it through direct-to-consumer testing without a doctor’s order. The test involves a simple finger stick or dried blood spot card. If you’re supplementing omega-3s and want to confirm you’re actually reaching therapeutic levels, this is the measurement to track.
Fish and Food Sources vs Supplementation
The highest dietary sources of EPA+DHA are fatty cold-water fish: wild salmon (1,500–2,500 mg EPA+DHA per 3oz serving), mackerel (2,200+ mg), sardines (1,300–1,800 mg), anchovies (900+ mg), and herring. Farmed salmon has variable omega-3 content depending on feed — historically high but declining as aquaculture has shifted to cheaper grain-based feeds.
Two to three servings of fatty fish per week can meaningfully raise omega-3 index. For most people in clinical practice, this is aspirational rather than realistic — few people consistently eat that much fatty fish. Supplementation reliably closes the gap without the mercury concerns associated with larger fish (which are concentrated in tuna, swordfish, and shark, not the smaller fatty fish that are the best omega-3 sources).
High-quality, molecularly distilled fish oil from anchovy, sardine, or mackerel sources (not salmon or tuna) has the lowest heavy metal contamination risk and the most favorable cost-per-gram-of-EPA+DHA. Look for third-party certification (IFOS 5-star, NSF, or USP) to confirm what the label says is actually in the capsule — this is an industry where label accuracy has historically been poor.
Frequently Asked Questions
Does fish oil actually thin the blood?
Fish oil reduces platelet aggregation — a mild antiplatelet effect. At standard doses (1,000–3,000 mg EPA+DHA daily), this is not clinically significant for most people and does not increase bleeding risk in surgical settings at normal doses. The FDA has not issued any warnings restricting fish oil use before surgery at standard supplemental doses. However, if you’re on anticoagulants like warfarin or clopidogrel, discuss omega-3 use with your prescribing physician — the combination requires monitoring.
How long does it take to see results from omega-3 supplementation?
Cell membrane turnover takes 3–4 months, which is why the omega-3 index reflects 3-month average status. Biochemical and inflammatory marker improvements (triglycerides, CRP) typically show measurable change at 6–8 weeks of consistent supplementation at therapeutic doses. Subjective improvements in joint comfort, sleep quality, and mood can sometimes be noticed within 2–4 weeks at higher doses. The full cardiovascular and anti-inflammatory benefit builds over 3–6 months of consistent supplementation.
Is fish oil safe to take every day long-term?
Yes — with the caveat that quality matters. High-quality, oxidation-tested fish oil taken at 2,000–4,000 mg EPA+DHA daily has an excellent long-term safety profile in the clinical literature, including studies extending over multiple years. The primary safety concern is oxidation — rancid fish oil increases oxidative stress rather than reducing it. Store fish oil in the refrigerator, check the expiration date, and choose supplements with oxidation testing documentation. If the capsule smells strongly fishy or rancid, discard it.
Can omega-3 help with joint pain?
Yes — this is one of the better-documented effects of therapeutic-dose omega-3 supplementation. A 2016 meta-analysis in Pain Medicine covering 17 randomized controlled trials found significant reductions in joint pain intensity, morning stiffness, and NSAID use in patients with rheumatoid arthritis taking omega-3 supplements. Effects were most pronounced at doses above 2,000 mg EPA+DHA daily and after 8+ weeks of supplementation. For non-inflammatory joint pain and tendinopathy, the mechanism is different (pro-resolution signaling rather than direct anti-inflammatory) but the clinical benefit is similar.
The Bottom Line
Omega-3 optimization is not complicated — but it does require intentionality. Most people who think they’re supplementing are either taking too little (subtherapeutic doses) or taking a form that’s poorly absorbed (ethyl ester at low concentration). Getting this right requires three decisions: choose the right form (triglyceride or rTG), take enough of it (2,000+ mg EPA+DHA daily for clinical benefit), and verify it’s working (omega-3 index testing every 6–12 months).
Combined with optimized vitamin D3 and adequate magnesium, omega-3 supplementation forms a foundational three-pillar protocol that addresses the three most prevalent nutritional deficiencies in Western adults and covers the broadest range of chronic disease risk factors. None of these are exotic. None are expensive relative to the consequences of deficiency. And none require a prescription.
Want to build a complete foundational supplement protocol? Book a private consultation with Dr. Tom for a personalized review of your current stack, lab work, and health goals — or explore the structured health courses at The Private Practice to understand the full science behind metabolic optimization.
Welcome to The Private Practice. I’m Dr. Tom. That’s the honest truth.
Dive Deeper
- Omega-3 EPA and DHA: The Evidence, the Dose, and Why Most Fish Oil Fails
- Omega-3 Fish Oil: EPA vs. DHA and Evidence-Based Benefits
- Anti-Inflammatory Diet: The Evidence-Based Protocol to Lower Inflammation
- Chronic Inflammation: The Silent Driver of Heart Disease, Diabetes, and More
- Brain Fog: The 8 Root Causes, How to Test for Each, and What to Do
See Also
- Depression & Neuroinflammation: The SMILES Trial, Omega-3, and MTHFR
- Magnesium for Migraines: What a Surgeon Takes (and Why It Works)
- Osteoporosis & Bone Health: Vitamin D, K2, Magnesium, and What DEXA Misses
- Senolytic Therapies and Longevity: Dasatinib, Quercetin, and Fisetin Evidence